Bioadvise Holding ApS: Financial statements 2023
CVR: 39919907
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Bioadvise Holding ApS (CVR 39919907) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK -29,230 compared with DKK -175,811 the year before. Equity in the 2023 report amounted to DKK 175,680. The solvency ratio was 84.5%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -29,230
- Equity
- DKK 175,680
- Total Assets
- DKK 207,911
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 0 | -29 t. | 176 t. | 0 |
| 2022 | - | 0 | -176 t. | 205 t. | 0 |
| 2021 | - | 0 | 53 t. | 381 t. | 0 |
| 2020 | - | 0 | 91 t. | 289 t. | 0 |
| 2019 | - | 0 | 197 t. | 198 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Bioadvise Holding ApS has published its annual report for 2022. Gross profit came to DKK 0, and the net result was DKK -175,811.
About Bioadvise Holding ApS
Bioadvise Holding ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Bioadvise Holding IVS. The management consists of Ditte Rinette Borum Andreasen. The company is owned by Ditte Rinette Borum Andreasen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK -58.